Work

Acute treatment of migraine with the selective 5-HT 1F receptor agonist lasmiditan – A randomised proof-of-concept trial

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Cephalalgia

DOI: 10.1177/0333102410375512

Authors: Michel D Ferrari, Markus Färkkilä, Uwe Reuter, Alison Pilgrim, Charles Davis, Martin Krauss, Hans-Christoph Diener, for the European COL-144 Investigators

Institutions: Leiden University Medical Center, University of Helsinki, Charité – Universitätsmedizin Berlin, CoLucid Pharmaceuticals (United States), FGK Clinical Research, University of Duisburg-Essen

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2125664611

FWCI: 9.605

Cites: 18

Cited by: 167

Related to: 10